Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.
Study Phase:
2
Recruitment Status:
Trial Completed
Study Drug(s):
Glutathione (Inhaled)
Number of Participants Being Recruited:
138
Single / Multi-Center:
Multi-Center
STUDY BACKGROUND INFORMATION:
This study will evaluate the safety and tolerability of aerolized glutathione compared with normal saline. The main outcome measure is pulmonary function testing (PFT).
ELIGIBILITY
Age:
>= 8 Years
FEV1:
40 - 90 Percent Predicted
P. aeruginosa status:
Not applicable
B. cepacia status:
Negative
Other Primary Eligibility Requirements:
Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific
trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.
